Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Antibiotic resistant infections 'continue to rise'
antibiotics
"Antimicrobial resistance is a major threat to the delivery of healthcare across the globe".
New report issued by Public Health England

The number of antibiotic resistant infections is continuing to rise, according to a new report by Public Health England (PHE).

Key findings:
  • Bloodstream infections caused by Escherichia coli rose by 15.6 per cent between 2010 and 2014. The proportion that were drug resistant remained constant
  • Bloodstream infections caused by Klebsiella pneumoniae rose by 20.8 per cent
  • Streptococcus pneumoniae bloodstream infections fell by 23 per cent, which is thought to be due to pneumococcal vaccination rates

On a positive note, the report shows a drop in the number of antibiotic prescriptions dispensed in primary care.

Despite this, the total antibiotic consumption in primary care actually increased by 6.5 per cent between 2011 and 2014. PHE says this suggests longer courses and/or higher dosages are being prescribed in general practice.

Use of broad spectrum antibiotics - which are most likely to drive antibiotic resistance - has fallen in primary care to 8.5 per cent. As a result, England is now the lowest prescriber of some of these drugs in the European Union.

The figures show that the highest proportion of these drugs are prescribed in secondary care. PHE says hospitals need to focus their efforts to ensure they prescribe broad-spectrum antibiotics for the right reasons and the right duration.

Commenting on the report, Dr Mike Durkin, NHS England director of patient safety, said: "Antimicrobial resistance is a major threat to the delivery of healthcare across the globe and these findings clearly show the need for both clinicians and patients to act now and do all they can to behave as responsible stewards of the use of antimicrobial medications.

"As one of the largest healthcare providers in the world, it is vital the NHS is seen to lead that fight against the global problem of antimicrobial resistance so these immensely important medicines can be preserved for now and future generations."

This new data has come from the second annual report of PHE's English Surveillance Programme for Antimicrobial Utilisation and Resistance. To read the report, visit: https://www.gov.uk/government/news/espaur-report-reveals-continued-rise-in-antibiotic-resistant-infections

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.